6550--Test Kits, reagents and supplies for Allergic Testing on Phadia Instrument

Where this opportunity stands

Every notice posted under solicitation 36C24526Q0192 in this department, oldest first.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

• Note the winner and the end of the period of performance for the recompete.
• Follow the agency to see the next notice for this work.

Who won similar work

88 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Veterans Affairs), same product/service code (PSC) 6550.

Single-winner award sizes (86): middle half $390K to $1.3M, median $694K; range $30K to $151.7M.

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

• Oct 6, 2026ABBOTT MOLECULAR INC.$920K6550--LAB - ABBOTT ALINITY-M PCR MOLECULAR REAGENTS & SUPPLIESMateriality: <0.01% of $ABT revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $920K award ÷ $45.1B revenue, 12 months to Mar 31, 2026 (SEC 10-Q). SEC
• Oct 2, 2026BECKMAN COULTER, INC.$291K6550--Intent to Sole Source | 3 Month Bridge Philadelphia VA Medical Center Laboratory Hematology/Chemistry TestingNo listed company matched (Materiality N/A)
• Oct 1, 2026SIEMENS HEALTHCARE DIAGNOSTICS INC.$600K6550--Blood Gas Analyzer Reagents, Controls, and Supplies IDIQNo listed company matched (Materiality N/A)
• Oct 1, 2026WERFEN USA LLC$388K6550--Werfen Immunocor Blood Bank Reagents and Supplies Northport and East OrangeNo listed company matched (Materiality N/A)
• Oct 1, 2026BECKMAN COULTER, INC$700KDrugs of Abuse ReagentsNo listed company matched (Materiality N/A)
• Oct 1, 2026QUIDELORTHO SALES COMPANY$125K6550--Blood Bank Reagents 5 Year OP IDIQ - DetroitMateriality: <0.01% of $QDEL revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $125K award ÷ $2.7B revenue, 12 months to Jun 28, 2026 (SEC 10-Q). SEC
• Oct 1, 2026BIOMERIEUX INC$284K6550--DO Biofire Panel Kits in support of the Sioux Falls VA HCSNo listed company matched (Materiality N/A)
• Sep 28, 2026NOVA BIOMEDICAL CORP$1.1M6550--Glucose Point of Care (POC) TestingNo listed company matched (Materiality N/A)
• Aug 28, 2026ROCHE DIAGNOSTICS CORPORATION$107K6550--Glucose Accu-Chek® Test StripsNo listed company matched (Materiality N/A)
• Aug 17, 2026WERFEN USA LLC$1.4M6550--Blood Type IVD ReagentsNo listed company matched (Materiality N/A)

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.